Estamos no ar no ! Saiba mais
ícone de PSP

Invesco Global Listed Private Equity ETF

55,72 USD
-0,46
0,82%
No fechamento Atualizado 16 de out. 16:00 EDT
1 dia
-0,82%
5 dias
-1,12%
1 mês
-4,93%
3 meses
-5,13%
6 meses
-9,32%
No acumulado do ano
-17,7%
1 ano
-17,05%
5 anos
-28,66%
10 anos
6,85%

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 50%
Neutro 50%
Negativo 0%
Positivo
Seeking Alpha
há 21 dias
The More These Dividend Machines Drop, The More I Buy
Leading blue-chip dividend machines have recently sold off quite aggressively. I detail several reasons why I am very happy about this development. I also share how I am taking advantage of the sell-off, including some of my favorite investments right now.
The More These Dividend Machines Drop, The More I Buy
Neutro
ETF Trends
há 2 meses
Risk-Wary Family Offices Double Down on Infrastructure
Geopolitical shocks have pushed family offices to rethink nearly every corner of their portfolios. Infrastructure has emerged as the asset class they trust most right now.
Risk-Wary Family Offices Double Down on Infrastructure
Neutro
Seeking Alpha
há 3 meses
Pace Of Private Equity Exits Slows In H1 2026
The number of private equity exits slowed during the first half of 2026, as market uncertainty continued to prevent buyers and sellers from finding common ground on valuations. Global private equity and venture capital firms announced 1,504 exits between Jan. 1 and June 30, down 6% from the 1,601 exits recorded in the first half of 2025, according to S&P Global Market Intelligence data.
Pace Of Private Equity Exits Slows In H1 2026
Neutro
Business Wire
há 4 meses
Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)
LILLE, France--(BUSINESS WIRE)-- #PSP--Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now e.
Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)
Positivo
Seeking Alpha
há 5 meses
Waymo's $16 Billion Round Drives Private Equity Investment Surge In Autonomous Vehicles
Global private equity investment in autonomous vehicles in the first four months of 2026 surged to its highest level in at least 10 years. Between Jan. 1 and April 28, transaction value in the sector totaled $23.26 billion, compared with $10.18 billion in all of 2025, according to S&P Global Market Intelligence data.
Waymo's $16 Billion Round Drives Private Equity Investment Surge In Autonomous Vehicles
Positivo
ETF Trends
ano passado
ETFs Offer Gateway to Once-Inaccessible Private Markets
Lately it seems as if most roads lead to the democratization of private markets.
ETFs Offer Gateway to Once-Inaccessible Private Markets
Neutro
ETF Trends
ano passado
3 Thoughts on Retail Advisors & Private Equity for 2H
Retail investing has long proved a tantalizing prospect for private equity players. Traditionally a space for limited partners with huge asset pools, like family offices, endowments, pension programs, high net worth individuals (HWNI) and more, private equity funds saw their doors open just slightly more to retail investors in May.
3 Thoughts on Retail Advisors & Private Equity for 2H
Negativo
Seeking Alpha
ano passado
PSP: Stay Away From This ETF, Strong Sell
PSP is a strong sell due to persistent underperformance versus SPY and its high expense ratio, eroding any potential alpha. Private equity exposure can be achieved more efficiently by directly holding top players like Blackstone, KKR, and Ares, avoiding ETF fees. PSP's asset mix dilutes returns by combining best-in-class managers with weaker players, resulting in subpar performance.
PSP: Stay Away From This ETF, Strong Sell
Neutro
ETF Trends
ano passado
PSP: An Efficient Avenue to Private Equity Access
The investing landscape is littered with vehicles that have auras of exclusivity. It feels as though it's off-limits to ordinary investors.
PSP: An Efficient Avenue to Private Equity Access
Positivo
Seeking Alpha
ano passado
PE Defense Investment Surges In Early 2025 As Geopolitics Drives Change
Private equity investment in defense swelled in early 2025, even as the investment landscape is quickly shifting in both the US and Europe. Recent policy decisions are changing the field of play for private equity defense investors.
PE Defense Investment Surges In Early 2025 As Geopolitics Drives Change
Gráficos de preços implementados com Lightweight Charts™